79 related articles for article (PubMed ID: 3664462)
1. Flow cytometry analysis of DNA damage and the evaluation of cytotoxicity of alkylating agents.
Frankfurt OS
Cancer Res; 1987 Nov; 47(21):5537-41. PubMed ID: 3664462
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric analysis of DNA damage and repair in the cells resistant to alkylating agents.
Frankfurt OS; Seckinger D; Sugarbaker EV
Cancer Res; 1990 Aug; 50(15):4453-7. PubMed ID: 2369722
[TBL] [Abstract][Full Text] [Related]
3. Intercellular transfer of drug resistance.
Frankfurt OS; Seckinger D; Sugarbaker EV
Cancer Res; 1991 Feb; 51(4):1190-5. PubMed ID: 1997161
[TBL] [Abstract][Full Text] [Related]
4. Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells.
Hansson J; Edgren M; Ehrsson H; Ringborg U; Nilsson B
Cancer Res; 1988 Jan; 48(1):19-26. PubMed ID: 3334994
[TBL] [Abstract][Full Text] [Related]
5. Detection of DNA damage in individual cells by flow cytometric analysis using anti-DNA monoclonal antibody.
Frankfurt OS
Exp Cell Res; 1987 Jun; 170(2):369-80. PubMed ID: 3036552
[TBL] [Abstract][Full Text] [Related]
6. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
[TBL] [Abstract][Full Text] [Related]
7. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
[TBL] [Abstract][Full Text] [Related]
8. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
Kramer RA; Greene K; Ahmad S; Vistica DT
Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
[TBL] [Abstract][Full Text] [Related]
9. Detection of cells resistant to alkylating agents by flow cytometric analysis of DNA damage.
Frankfurt OS; Seckinger D; Sugarbaker EV
Cytometry; 1990; 11(8):894-900. PubMed ID: 2272249
[TBL] [Abstract][Full Text] [Related]
10. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
Ono K; Shrieve DC
J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
[TBL] [Abstract][Full Text] [Related]
11. Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy.
Anderson CP; Reynolds CP
Bone Marrow Transplant; 2002 Aug; 30(3):135-40. PubMed ID: 12189530
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometry analysis of single-strand DNA damage in neuroblastoma cell lines using the F7-26 monoclonal antibody.
Grigoryan RS; Yang B; Keshelava N; Barnhart JR; Reynolds CP
Cytometry A; 2007 Nov; 71(11):951-60. PubMed ID: 17879237
[TBL] [Abstract][Full Text] [Related]
13. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
[TBL] [Abstract][Full Text] [Related]
14. Effects of L-phenylalanine mustard and L-buthionine sulfoximine on murine and human hematopoietic progenitor cells in vitro.
Du DL; Volpe DA; Grieshaber CK; Murphy MJ
Cancer Res; 1990 Jul; 50(13):4038-43. PubMed ID: 2354454
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms involved in the potentiation of melphalan by the bioreductive compound THNLA-1 in vitro.
Papadopoulou MV; Ji M; Khan SH; Bloomer WD
Oncol Res; 1999; 11(8):345-57. PubMed ID: 10803738
[TBL] [Abstract][Full Text] [Related]
16. Selective enhancement of hypoxic cell killing by melphalan via thiol depletion: in vitro studies with hypoxic cell sensitizers and buthionine sulfoximine.
Roizin-Towle L
J Natl Cancer Inst; 1985 Jan; 74(1):151-7. PubMed ID: 3155814
[TBL] [Abstract][Full Text] [Related]
17. Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo.
Teicher BA; Holden SA; Eder JP; Brann TW; Jones SM; Frei E
Cancer Res; 1989 Nov; 49(21):5994-8. PubMed ID: 2790813
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of DNA repair in cells treated with a combination of alkylating agents.
Frankfurt OS; Seckinger D; Sugarbaker EV
Anticancer Res; 1993; 13(4):947-52. PubMed ID: 8352564
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle-dependent cytotoxicity of alkylating agents: determination of nitrogen mustard-induced DNA cross-links and their repair in Chinese hamster ovary cells synchronized by centrifugal elutriation.
Murray D; Meyn RE
Cancer Res; 1986 May; 46(5):2324-9. PubMed ID: 3697977
[TBL] [Abstract][Full Text] [Related]
20. Rescue from enhanced alkylator-induced cell death with low molecular weight sulfur-containing chemoprotectants.
Muldoon LL; Walker-Rosenfeld SL; Hale C; Purcell SE; Bennett LC; Neuwelt EA
J Pharmacol Exp Ther; 2001 Mar; 296(3):797-805. PubMed ID: 11181909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
